ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find attached herewith the Annual Secretarial Compliance Report for the Financial Year 2023-24 issued by M/s. Samdani Shah & Kabra, Practicing Company Secretaries. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the intimation dated 17th May, 2024 received from our RTA. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcripts of the Earnings Call held on 9th May, 2024. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith the intimation dated 14th May, 2024 received from our RTA. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Please find enclosed herewith the Amended Memorandum and Articles of Association of the Company w.e.f. 12th May, 2024. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Please find enclosed herewith the Scrutinizer''s Report dated 13th May regarding the Postal Ballot. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Please find enclosed herewith the Voting Results along with Scrutinizer''s Report of the Postal Ballot Notice dated 29th March, 2024. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the Newspaper Publication dated 11th May, 2024. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the intimation dated 10th May, 2024 received from our RTA.
Alembic Pharma Q4 Results Review - New Launches In U.S., Capacity Utilisation To Drive Growth: Nirmal Bang
Domestic business grew by ~3% YoY to Rs 5.03 billion.